BioCentury
ARTICLE | Clinical News

Naltrexone depot: Completed Phase III study enrollment

March 12, 2001 8:00 AM UTC

DrugAbuse Sciences Inc., Los Altos, Calif. Product: Naltrexone depot Business: Neurological Therapeutic category: Receptor antagonist Target: Opioid receptors Description: Slow release injectable for...